A phase II trial to assess the impact of b2 adrenergic blockade in immune checkpoint inhibitor (ICI)- refractory metastatic triple negative breast cancer (mTNBC)

被引：0
|
作者：
Gandhi, Shipra [1 ]
Roy, Arya Mariam [1 ]
Minderman, Hans [1 ]
Rosario, Spencer [1 ]
Repasky, Elizabeth A. [1 ]
机构：
[1] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS1141
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer
    Jasmeet Chadha Singh
    Yelena Novik
    Stacey Stein
    Matthew Volm
    Marlene Meyers
    Julia Smith
    Coral Omene
    James Speyer
    Robert Schneider
    Komal Jhaveri
    Silvia Formenti
    Victoria Kyriakou
    Benson Joseph
    Judith D Goldberg
    Xiaochun Li
    Sylvia Adams
    Amy Tiersten
    Breast Cancer Research, 16
  • [32] Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer
    Singh, Jasmeet Chadha
    Novik, Yelena
    Stein, Stacey
    Volm, Matthew
    Meyers, Marlene
    Smith, Julia
    Omene, Coral
    Speyer, James
    Schneider, Robert
    Jhaveri, Komal
    Formenti, Silvia
    Kyriakou, Victoria
    Joseph, Benson
    Goldberg, Judith D.
    Li, Xiaochun
    Adams, Sylvia
    Tiersten, Amy
    BREAST CANCER RESEARCH, 2014, 16 (02):
  • [33] A phase Ib/II study of leronlimab combined with carboplatin in patients with CCR5+metastatic triple-negative breast cancer (mTNBC)
    Cristofanilli, Massimo
    Chittoria, Namita
    Ehsani, Sima
    Rui, Hallgeir
    Dolezal, Milana
    Stork-Sloots, Lisette
    de Snoo, Femke
    Recknor, Christopher
    Abramson, Vandana
    CANCER RESEARCH, 2022, 82 (04)
  • [34] A Phase 2 trial of RAD 001 and Carboplatin in patients with triple negative metastatic breast cancer
    Singh, J. C.
    Volm, M.
    Novik, Y.
    Speyer, J.
    Adams, S.
    Omene, C. O.
    Meyers, M.
    Smith, J. A.
    Schneider, R.
    Formenti, S.
    Goldberg, J. D.
    Li, X.
    Davis, S.
    Beardslee, B.
    Tiersten, A.
    CANCER RESEARCH, 2012, 72
  • [35] Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells
    Vito, Alyssa
    Salem, Omar
    El-Sayes, Nader
    MacFawn, Ian P.
    Portillo, Ana L.
    Milne, Katy
    Harrington, Danielle
    Ashkar, Ali A.
    Wan, Yonghong
    Workenhe, Samuel T.
    Nelson, Brad H.
    Bruno, Tullia C.
    Mossman, Karen L.
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [36] Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells
    Alyssa Vito
    Omar Salem
    Nader El-Sayes
    Ian P. MacFawn
    Ana L. Portillo
    Katy Milne
    Danielle Harrington
    Ali A. Ashkar
    Yonghong Wan
    Samuel T. Workenhe
    Brad H. Nelson
    Tullia C. Bruno
    Karen L. Mossman
    Communications Biology, 4
  • [37] Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial
    Shaashua, Lee
    Shabat-Simon, Maytal
    Haldar, Rita
    Matzner, Pini
    Zmora, Oded
    Shabtai, Moshe
    Sharon, Eran
    Allweis, Tanir
    Barshack, Iris
    Hayman, Lucile
    Arevalo, Jesusa
    Ma, Jeffrey
    Horowitz, Maya
    Cole, Steven
    Ben-Eliyahu, Shamgar
    CLINICAL CANCER RESEARCH, 2017, 23 (16) : 4651 - 4661
  • [38] Case Report: Significant Response to the Combination of Lenvatinib and Immune Checkpoint Inhibitor in a Patient With Heavily Pretreated Metastatic Triple Negative Breast Cancer
    Lee, Jin Sun
    Yost, Susan E.
    Yuan, Yuan
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [39] A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic triple negative breast cancer
    Cowherd, S.
    Miller, L. D.
    Melin, S. A.
    Akman, S.
    Isom, S.
    Cole, J.
    Pullikuth, A.
    Lawrence, J. A.
    CANCER BIOLOGY & THERAPY, 2015, 16 (05) : 678 - 683
  • [40] A single-arm, phase II study assessing the efficacy of pembrolizumab (pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC).
    McArthur, Heather L.
    Barker, Christopher Andrew
    Gucalp, Ayca
    Lebron-Zapata, Lizza
    Wen, Yong Hannah
    Phung, Anh
    Rodine, Micaela
    Arnold, Brittany
    Zhang, Zhigang
    Ho, Alice
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
12345